Tempus Labs Japan Launch: Success Metrics for Genomic Sequencing Platform

You're the PM for Tempus Labs, launching an AI-powered genomic sequencing platform for oncologists in Japan. This market has unique regulatory and data privacy landscapes. What key metrics would you define for the first 6-12 months to assess the initial success and market fit?

Community approaches

No community approaches yet. Be the first to share your thinking.